Issue 4/2012
Content (27 Articles)
Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
Shumpei Yokota, Tomoyuki Imagawa, Takuji Murata, Minako Tomiita, Yasuhiko Itoh, Satoshi Fujikawa, Syuji Takei, Masaaki Mori
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka
Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases
Yuji Yoshida, Yuko Takahashi, Nobuyoshi Minemura, Yo Ueda, Hiroyuki Yamashita, Hiroshi Kaneko, Akio Mimori
Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms
Shunsuke Mori, Kaoru Terada, Yukitaka Ueki
Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case–control study
Abqariyah Yahya, Camilla Bengtsson, Too Chun Lai, Per T. Larsson, Amal Nasir Mustafa, Nor Aini Abdullah, Norasiah Muhamad, Heselynn Hussein, Lars Klareskog, Lars Alfredsson, Shahnaz Murad
Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis
Motoaki Hoshino, Taku Yoshio, Sachiko Onishi, Seiji Minota
Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL
Takumi Furuya, Minori Koga, Koki Hikami, Aya Kawasaki, Naoyuki Tsuchiya
Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis
Jing Li, Jin-Hui Tao, Wei Gao, Ye Fan, Man-Man Lu, Rui Li, Xiang-Pei Li, Dong-Qing Ye
Erratum to: Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis
Jing Li, Jin-Hui Tao, Wei Gao, Ye Fan, Man-Man Lu, Rui Li, Xiang-Pei Li, Dong-Qing Ye
Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis
Remi Ozawa, Yutaka Inaba, Masaaki Mori, Ryoki Hara, Masako Kikuchi, Rumiko Higuchi, Takako Miyamae, Tomoyuki Imagawa, Takeo Fujiwara, Tomoyuki Saito, Shumpei Yokota
Prospective monitoring of Epstein–Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab
Jun-ichi Kawada, Naomi Iwata, Yoshiro Kitagawa, Hiroshi Kimura, Yoshinori Ito
The role of resistin in Behçet’s disease: a Turkish experiment
Yavuz Pehlivan, Ahmet Mesut Onat, Seydi Okumuş, Bunyamin Kisacik, Gazi Comez, Aysegul Comez, Fatih Goktepe, Nurdan Ozlu Ceylan
Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis
Naohiko Aozasa, Yoshihide Asano, Kaname Akamata, Shinji Noda, Yuri Masui, Zenshiro Tamaki, Yayoi Tada, Makoto Sugaya, Takafumi Kadono, Shinichi Sato
High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome
Tomoki Origuchi, Kazuhiko Arima, Shin-ya Kawashiri, Mami Tamai, Satoshi Yamasaki, Hideki Nakamura, Toshiaki Tsukada, Toshiyuki Aramaki, Masako Furuyama, Taiichiro Miyashita, Yojiro Kawabe, Nozomi Iwanaga, Kaoru Terada, Yukitaka Ueki, Takaaki Fukuda, Katsumi Eguchi, Atsushi Kawakami
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
Shigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, Aileen L. Pangan, Shringi Sharma, L. Steven Brown, Nobuyuki Miyasaka
Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases
Takehiro Takahashi, Yoshihide Asano, Eisuke Amiya, Masaru Hatano, Zenshiro Tamaki, Atsuko Ozeki, Aya Watanabe, Shuichi Kawarasaki, Tomoko Nakao, Takashi Taniguchi, Yohei Ichimura, Tetsuo Toyama, Masafumi Watanabe, Yasunobu Hirata, Ryozo Nagai, Shinichi Sato
Morphea associated with the use of adalimumab: a case report and review of the literature
Julio Ramírez, M. Victoria Hernández, Javier Galve, Juan D. Cañete, Raimon Sanmartí
Positional occlusion of the vertebral artery in a case of rheumatoid atlantoaxial subluxation presenting with multiple cerebral and cerebellar infarction
Hiroyasu Fujiwara, Takashi Kaito, Takahiro Makino, Kazuo Yonenobu
Three cases of pneumatosis intestinalis presenting in autoimmune diseases
Akihiro Sagara, Kiyoki Kitagawa, Kengo Furuichi, Shinji Kitajima, Tadashi Toyama, Toshiya Okumura, Akinori Hara, Yoshio Sakai, Shuichi Kaneko, Takashi Wada
Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener’s)
Azusa Umemoto, Hidekazu Ikeuchi, Keiju Hiromura, Hiroko Hamatani, Noriyuki Sakurai, Toru Sakairi, Takayuki Matsumoto, Akito Maeshima, Takashi Kuroiwa, Yoshihisa Nojima
Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab
Shunichiro Takezaki, Yuka Okura, Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Makoto Kaneda, Yuko Cho, Masafumi Yamada, Nobuaki Kawamura, Akihiro Iguchi, Ichiro Kobayashi, Tadashi Ariga
Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies
Shinji Sato, Masataka Kuwana, Takashi Fujita, Yasuo Suzuki
The rapid efficacy of abatacept in a patient with rheumatoid vasculitis
Wataru Fujii, Masataka Kohno, Hidetaka Ishino, Amane Nakabayashi, Kazuki Fujioka, Takashi Kida, Hidetake Nagahara, Ken Murakami, Kaoru Nakamura, Takahiro Seno, Aihiro Yamamoto, Yutaka Kawahito
Radiographic remodeling of the shoulder joint in a patient with rheumatoid arthritis after 4 years of treatment with etanercept
Toshifumi Ozaki, Kenzo Hashizume, Ryuichi Nakahara, Keiichiro Nishida
Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Takao Nagashima, Hitoaki Okazaki, Yasuyuki Kamata, Seiji Minota
Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Isamu Yokoe, Shinya Nishio, Hiroshi Sato, Hitomi Kobayashi
Erratum to: Reply to: Comment on ‘‘Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks’’ by Yokoe et al.
Isamu Yokoe, Shinya Nishio, Hiroshi Sato, Hitomi Kobayashi